02.06.2021 MPH Health Care AG  DE000A289V03

DGAP-News: MPH Health Care AG: result Q1-2021


 

DGAP-News: MPH Health Care AG / Key word(s): Quarterly / Interim Statement/Miscellaneous
MPH Health Care AG: result Q1-2021

02.06.2021 / 08:30
The issuer is solely responsible for the content of this announcement.


MPH Health Care AG: result Q1-2021

MPH Health Care AG with a good start into the year: EBIT amounts to EUR 22.5 million in Q1. Equity (net asset value) rises to EUR 223.4 million, corresponding to EUR 52.19 per share.

Berlin, 2 June 2021: In the first quarter of 2021, MPH Health Care AG (ISIN: DE000A289V03) benefited from the recovery of the stock market prices of its listed investments and achieved an operating result (EBIT) according to IFRS of EUR 22.5 million (same period previous year: EUR -88.4 million).

Equity increased by 11.0% to EUR 223.4 million (31.12.2020: EUR 201.3 million). Net asset value (NAV) per share increased accordingly from EUR 47.01 to EUR 52.19. The equity ratio as at 31.03.2021 increased slightly to 96.0% (31.12.2020: 95.5%).

The investment M1 Kliniken AG had a successful start into the year 2021 with a significant increase in revenues and earnings in the two business segments "Beauty" and "Trade". Consolidated revenue rose to around EUR 81 million in the first quarter of 2021 (previous year EUR 23 million) and EBITDA to EUR 4.0 million (previous year EUR 1.4 million).

In the Beauty segment, the new year had a slow start (due to the ongoing Corona pandemic) with treatment figures around 20% below the previous year. However, by the end of the quarter, M1 was back to historic peak daily sales and continued to grow. In Q1-2021 as a whole, almost 81 thousand treatments were carried out compared to 73 thousand treatments in the same quarter of the previous year. By the end of May 2021, four new specialist centers had already been opened in the German market. According to current planning, a total of 50 M1 specialist centers are planned by the end of 2021, with further locations also opening in foreign markets.

In the trading segment, the operational optimization of the business activities of HAEMATO AG continued, which was able to report an increase in turnover in the past quarter compared to the previous year. In the process, HAEMATO AG was able to significantly improve its profitability. The share price of M1 Kliniken AG improved from 9.24 euros on 31 December 2020 to 10.85 euros on 31 March 2021.

Our second listed investment CR Capital AG (formerly CR Capital Real Estate AG) was also able to continue on its successful path in 2021 - almost unaffected by the COVID-19 pandemic - and continued to grow profitably. In the first three months, CR Capital was already able to notarially sell 161 residential units with a sales volume of approx. EUR 54 million in the projects Rousseau Park in the Berlin suburbs and Leipzig-Schkeuditz via participation Terrabau. The share price of CR Capital AG has increased from EUR 30.50 on 31 December 2020 to EUR 32.50 on 31 March 2021.

With an increasing easing of the Corona restrictions due to rising vaccination rates and falling case numbers, we are confident about the further development of our investments. All M1 Med Beauty locations in Germany and abroad have been reopened in the meantime, HAEMATO AG is making an important contribution to the Corona pandemic with the sale of medical products for Covid-19 diagnostics, and CR Capital AG has so far been able to record a continually strong demand for affordable residential real estate.

Due to the ongoing Corona pandemic, MPH Health Care AG will make use of the option to invite shareholders to the company's Annual General Meeting scheduled for 15 July 2021 with a shortened notice period of 21 days.

About MPH Health Care AG:
MPH AG is an investment company with a strategic focus on the purchase, development and sale of companies and company shares, especially in growth segments of the health care market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potentials outside the healthcare market from high-growth and high-yield sectors.

MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.


Contact:
Patrick Brenske, Management Board
Corporate Communications
E-Mail: [email protected]


02.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MPH Health Care AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: 030 / 863 21 45 60
Fax: 030 / 863 21 45 69
E-mail: [email protected]
Internet: www.mph-ag.de
ISIN: DE000A289V03, DE000A289VT5
WKN: A289V0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1203367

 
End of News DGAP News Service

1203367  02.06.2021 

fncls.ssp?fn=show_t_gif&application_id=1203367&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2015 2016 2017 2018 2019 2020 2021e
Umsatzerlöse1 273,62 329,22 0,03 39,53 41,22 3,43 42,00
EBITDA1,2 17,64 13,91 -0,65 37,69 11,59 -70,99 41,00
EBITDA-Marge3 6,45 4,23 -2.166,67 95,35 28,12 -2.069,68 97,62
EBIT1,4 13,15 7,89 -0,68 37,64 11,58 -71,02 40,20
EBIT-Marge5 4,81 2,40 -2.266,67 95,22 28,09 -2.070,55 95,71
Jahresüberschuss1 84,10 80,10 31,86 37,02 11,08 -70,38 36,00
Netto-Marge6 30,74 24,33 106.200,00 93,65 26,88 -2.051,90 85,71
Cashflow1,7 2,75 -4,77 1,01 5,20 -1,35 -2,89 0,00
Ergebnis je Aktie8 19,60 18,70 7,40 8,60 2,60 -16,44 8,40
Dividende8 1,20 1,20 2,00 2,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2020 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Harry Haseloff

INVESTOR-INFORMATIONEN
©boersengefluester.de
MPH Health Care
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A289V0 22,500 Halten 96,33
KGV 2022e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
6,82 8,19 0,84 4,56
KBV KCV KUV EV/EBITDA
0,43 - 28,07 -1,41
Dividende '20 in € Dividende '21e in € Div.-Rendite '21e
in %
Hauptversammlung
0,00 0,00 0,00 15.07.2021
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.06.2021 02.09.2021 02.12.2021 28.05.2021
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-3,75% -14,93% -2,17% -2,17%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MPH Health Care AG  ISIN: DE000A289V03 können Sie bei DGAP abrufen

Beteiligungen , A289V0 , 93M1 , XETR:93M1